Publications by authors named "Zbigniew Puch"

Claim this Profile
T
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes.
Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska, Ewa Paliczka-Cieslik, Daria Handkiewicz-Junak, Zbigniew Puch

Arch Med Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma.
Aleksandra Kukulska, Jolanta Krajewska, Zofia Kolosza, Ewa Paliczka-Cieslik, Aleksandra Kropinska, Zbigniew Puch

Endocr Connect· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma.
Jolanta Krajewska, Michal Jarzab, Aleksandra Kukulska, Agnieszka Czarniecka, Jozef Roskosz, Zbigniew Puch

Nucl Med Mol Imaging· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.
Barbara Jarząb, Marek Dedecjus, Dorota Słowińska-Klencka, Andrzej Lewiński, Zbigniew Adamczewski, Zbigniew Puch

Endokrynol Pol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
Dorota Kula, Michał Kalemba, Zbigniew Puch, Joanna Polańska, Michał Świerniak

Endokrynol Pol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Jolanta Krajewska, Michał Jarząb, Agnieszka Czarniecka, Józef Roskosz, Aleksandra Kukulska, Zbigniew Puch

Endokrynol Pol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
Daria Handkiewicz-Junak, Tomasz Gawlik, Jozef Rozkosz, Zbigniew Puch, Barbara Michalik

Eur J Endocrinol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
Huiling He, Agnieszka Bronisz, Sandya Liyanarachchi, Rebecca Nagy, Wei Li, Zbigniew Puch

J Clin Endocrinol Metab· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Suppressive thyroxine therapy of differentiated thyroid cancer in daily practice of a large cancer centre].
Zbigniew Puch, Józef Roskosz, Beata Jurecka-Lubieniecka, Dorota Kula

Endokrynol Pol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic predisposition to papillary thyroid cancer.
Dorota Kula, Michał Kalemba, Beata Jurecka-Lubieniecka, Zbigniew Puch, Małgorzata Kowalska

Endokrynol Pol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and treatment of thyroid cancer - Polish guidelines].
Barbara Jarząb, Stanisław Sporny, Dariusz Lange, Jan Włoch, Andrzej Lewiński, Zbigniew Puch

Endokrynol Pol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi.
Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska-Suwińska, Zbigniew Puch, Ewa Paliczka-Cieslik

Thyroid Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.
Daria Handkiewicz-Junak, Jozef Roskosz, Kornelia Hasse-Lazar, Sylwia Szpak-Ulczok, Zbigniew Puch

Thyroid Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi].
Aleksandra Kukulska, Jolanta Krajewska, Józef Roskosz, Daria Handkiewicz-Junak, Michał Jarzab, Zbigniew Puch

Endokrynol Pol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Relapse of differentiated thyroid carcinoma in low-risk patients].
Jolanta Krajewska, Agnieszka Czarniecka, Michał Jarzab, Aleksandra Kukulska, Daria Hankiewicz-Junak, Zbigniew Puch

Endokrynol Pol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical course and treatment of patients with differentiated thyroid carcinoma diagnosed during the year 1995].
Agnieszka Czarniecka, Jan Włoch, Michał Jarzab, Jolanta Krajewska, Aleksandra Kukulska, Zbigniew Puch

Endokrynol Pol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.
Barbara Jarzab, Daria Handkiewicz-Junak, Józef Roskosz, Zbigniew Puch, Zbigniew Wygoda

Eur J Nucl Med Mol Imaging· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis